AzTrials
AzTrials

Accident, TrafficNCT07051395

Correlation Between Coagulation Profiles And Injury Severity In Road Traffic Accidents Patients at Dera Ismail Khan

An observational study of Accident, Traffic, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Trauma-induced coagulopathy (TIC), also known as acute traumatic coagulopathy (ATC), is a common condition in patients with severe trauma, particularly in road traffic accident (RTA) victims. Coagulopathy is often associated with high mortality rates and poor outcomes in trauma patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Accident, Traffic
What is being tested?
Road Traffic Accidents Patient
How many people
230 participants
Where
1 sitePakistan
Study dates
17 Mar 2025to 1 Mar 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: To assess the correlation between coagulation profiles and injury severity in trauma patients, with a focus on the prevalence of trauma-induced coagulopathy (TIC) in road traffic accident (RTA) cases at a tertiary care hospital in Dera Ismail Khan. Methods: A cross-sectional observational study will be conducted in the Accident \& Emergency (A\&E) Department and Trauma Center of DHQ Hospital, Dera Ismail Khan. The study population includes patients aged 18 years and above, with moderate to severe injuries (Injury Severity Score ≥ 15),

Who may be able to join

  • Patients with moderate to severe injuries (Injury Severity Score>15).
  • All Patients will be admitted in Accident and Emergency Center after the accident.

Who cannot join

  • Patients with Mild injury and score <15.
  • Patients with pre-existing coagulation disorders (e.g., hemophilia).
  • Patients on anticoagulant therapy prior to admission.
  • Patients with incomplete medical records or insufficient blood samples.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Mufti Mehmood Memorial Teaching Hospital

    Dera Ismāīl Khān, Khyber Pakhtunkhwa

Other trials in Pakistan

About this study

Trauma-induced coagulopathy (TIC), also known as acute traumatic coagulopathy (ATC), is a common condition in patients with severe trauma, particularly in road traffic accident (RTA) victims. Coagulopathy is often associated with high mortality rates and poor outcomes in trauma patients.

Read the detailed description

The study explores the correlation between coagulation profiles and the severity of injuries in patients admitted to a tertiary care hospital following RTAs.

Being tested
Road Traffic Accidents Patient

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Road Traffic Accidents PatientDiagnostic test

    Coagulation Profiles And Injury Severity In Road Traffic Accidents Patients at Dera Ismail Khan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self Admisnistred questioner

    A Self Admisnistred questioner is used to collect the data and details of the accident

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jul 2025
  2. Study start17 Mar 2025
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
230 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07051395
Sponsor's protocol ID
MSAHSW/Batch-Fall23/922
Status last verified
Jun 2025
First submitted
26 Jun 2025
Last updated
4 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Accident, Traffic, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 4 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self Admisnistred questioner (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in